Arbutus Biopharma Corp (ABUS) SEC Filings — 2024

Filings

• Arbutus Biopharma Files 8-K — 8-K · Nov 15, 2024
• Arbutus Biopharma Corp SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• Arbutus Biopharma Files 8-K — 8-K · Nov 6, 2024
• Arbutus Biopharma Reports Q3 2024 Results — 10-Q · Nov 6, 2024
• Arbutus Biopharma Files 8-K — 8-K · Oct 15, 2024
• Arbutus Biopharma Reports Director Changes and Compensation — 8-K · Oct 11, 2024
• Arbutus Biopharma Files Q2 2024 10-Q — 10-Q · Aug 8, 2024
• Arbutus Biopharma Files 8-K for Regulation FD Disclosure — 8-K · Aug 5, 2024
• Arbutus Biopharma Files 8-K with Operational Updates — 8-K · Aug 1, 2024
• Arbutus Biopharma Corp SC 13G Filing — SC 13G · Jun 10, 2024
• Arbutus Biopharma Files 8-K, Changes Address — 8-K · Jun 6, 2024
• Arbutus Biopharma Files 8-K — 8-K · Jun 5, 2024
• Arbutus Biopharma Corp. Announces Board and Executive Changes — 8-K · May 28, 2024
• Arbutus Biopharma Corp Files 8-K — 8-K · May 22, 2024
• Whitefort Capital Amends Arbutus Biopharma Stake — SC 13D/A · May 17, 2024
• Whitefort Capital Files 13D on Arbutus Biopharma — SC 13D · May 9, 2024
• Arbutus Biopharma Appoints New CEO, Dr. Sofia — 8-K · May 2, 2024
• Arbutus Biopharma Corp Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 2, 2024
• Arbutus Biopharma Corp. Announces 2024 Annual General and Special Meeting — DEF 14A · Apr 10, 2024
• Arbutus Biopharma Files 8-K — 8-K · Apr 4, 2024
• Arbutus Biopharma Corp. Files 2023 Annual Report on Form 10-K — 10-K · Mar 5, 2024
• Arbutus Biopharma Files 8-K on Financial Condition — 8-K · Feb 29, 2024
• Arbutus Biopharma Corp SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• Arbutus Biopharma Corp SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• BlackRock Amends Arbutus Biopharma Stake, Maintains Passive Position — SC 13G/A · Feb 12, 2024
• Arbutus Biopharma Confirms Nasdaq Listing for ABUS Common Shares — 8-K · Jan 8, 2024
• Arbutus Biopharma Reports Executive Changes, Compensation on Dec 31 — 8-K · Jan 4, 2024